Drug · DIN 02372673
Q-RISPERIDONE
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since August 21, 2015.
- Drug Identification Number (DIN)
- 02372673
- Company (DIN owner)
- Qd Pharmaceuticals UlcEtobicoke, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Risperidone N05AX08
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RISPERIDONE | 4 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 22, 2011: NOC 12648Abbreviated New Drug Submission (ANDS) · New Maufacturer and Product Name
Other DINs named Q-RISPERIDONE
- DIN 02372622 · Cancelled Pre Market
- DIN 02372630 · Cancelled Pre Market
- DIN 02372649 · Cancelled Pre Market
- DIN 02372657 · Cancelled Pre Market
- DIN 02372665 · Cancelled Pre Market